Treace Medical Concepts (TMCI) Cost of Revenue (2020 - 2025)
Historic Cost of Revenue for Treace Medical Concepts (TMCI) over the last 6 years, with Q3 2025 value amounting to $34.4 million.
- Treace Medical Concepts' Cost of Revenue rose 502.21% to $34.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $140.5 million, marking a year-over-year decrease of 678.27%. This contributed to the annual value of $147.6 million for FY2024, which is 479.01% up from last year.
- Latest data reveals that Treace Medical Concepts reported Cost of Revenue of $34.4 million as of Q3 2025, which was up 502.21% from $33.1 million recorded in Q2 2025.
- In the past 5 years, Treace Medical Concepts' Cost of Revenue registered a high of $40.3 million during Q1 2024, and its lowest value of $12.1 million during Q1 2021.
- In the last 5 years, Treace Medical Concepts' Cost of Revenue had a median value of $33.1 million in 2025 and averaged $29.6 million.
- In the last 5 years, Treace Medical Concepts' Cost of Revenue soared by 19254.54% in 2021 and then crashed by 1219.98% in 2025.
- Over the past 5 years, Treace Medical Concepts' Cost of Revenue (Quarter) stood at $23.3 million in 2021, then rose by 29.35% to $30.1 million in 2022, then soared by 32.68% to $39.9 million in 2023, then fell by 7.68% to $36.9 million in 2024, then decreased by 6.61% to $34.4 million in 2025.
- Its Cost of Revenue was $34.4 million in Q3 2025, compared to $33.1 million in Q2 2025 and $36.1 million in Q1 2025.